Cargando…
miR-124 as a Liquid Biopsy Prognostic Biomarker in Small Extracellular Vesicles from NSCLC Patients
Despite advances in non-small cell lung cancer (NSCLC) research, this is still the most common cancer type that has been diagnosed up to date. microRNAs have emerged as useful clinical biomarkers in both tissue and liquid biopsy. However, there are no reliable predictive biomarkers for clinical use....
Autores principales: | Sanchez-Cabrero, Darío, Garcia-Guede, Álvaro, Burdiel, Miranda, Pernía, Olga, Colmenarejo-Fernandez, Julián, Gutierrez, Laura, Higuera, Oliver, Rodriguez, Isabel Esteban, Rosas-Alonso, Rocío, Rodriguez-Antolín, Carlos, Losantos-García, Itsaso, Vera, Olga, De Castro-Carpeño, Javier, Ibanez de Caceres, Inmaculada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10380700/ https://www.ncbi.nlm.nih.gov/pubmed/37511221 http://dx.doi.org/10.3390/ijms241411464 |
Ejemplares similares
-
MiR-151a: a robust endogenous control for normalizing small extracellular vesicle cargo in human cancer
por: Burdiel, Miranda, et al.
Publicado: (2023) -
miR-7 methylation as a biomarker to predict poor survival in early-stage non-small cell lung cancer patients
por: Rodríguez-Antolín, Carlos, et al.
Publicado: (2019) -
Prognostic Impact of Dihydropyrimidine Dehydrogenase Germline Variants in Unresectable Non-Small Cell Lung Cancer Patients Treated with Platin-Based Chemotherapy
por: Guijarro-Eguinoa, Javier, et al.
Publicado: (2023) -
Clinical validation of a novel quantitative assay for the detection of MGMT methylation in glioblastoma patients
por: Rosas-Alonso, Rocio, et al.
Publicado: (2021) -
A Novel Role for the Tumor Suppressor Gene ITF2 in Tumorigenesis and Chemotherapy Response
por: Pernía, Olga, et al.
Publicado: (2020)